Partial lipodystrophy – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Sat, 13 Jun 2026 04:02:40 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Partial lipodystrophy – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Metreleptin for Patients with Partial Lipodystrophy https://clinicaltrials.eu/trial/study-on-metreleptin-for-patients-with-partial-lipodystrophy/ Mon, 04 May 2026 07:50:31 +0000 https://clinicaltrials.eu/trial/study-on-metreleptin-for-patients-with-partial-lipodystrophy/ This clinical trial is focused on studying a condition called partial lipodystrophy. This is a rare disorder where the body is unable to store fat properly, leading to a lack of fat in certain areas of the body. The study will evaluate the effects of a treatment called Metreleptin, which is a protein that helps regulate fat and energy balance in the body. Participants in the study will receive either Metreleptin or a placebo, which is a substance with no active medication, to compare the effects.

The purpose of the study is to assess the safety and effectiveness of daily injections of Metreleptin over a 12-month period. Participants will receive the treatment through a subcutaneous injection, which means the medication is injected under the skin. The study will monitor changes in health markers such as blood sugar levels and fat levels in the blood, which are often affected in people with partial lipodystrophy.

Throughout the study, participants will have regular check-ups to track their progress and any changes in their condition. The study aims to provide valuable information on how Metreleptin can help manage partial lipodystrophy and improve the quality of life for those affected by this condition.

]]> Study on the Effects of Metreleptin for Patients with Partial Lipodystrophy https://clinicaltrials.eu/trial/study-on-the-effects-of-metreleptin-for-patients-with-partial-lipodystrophy/ Wed, 29 Apr 2026 14:26:34 +0000 https://clinicaltrials.eu/trial/study-on-the-effects-of-metreleptin-for-patients-with-partial-lipodystrophy/ This clinical trial is focused on studying a condition known as Partial Lipodystrophy. This is a rare disorder where the body is unable to store fat properly, leading to a lack of fat tissue in certain areas. The treatment being tested in this study is called Metreleptin, which is a medication given as a daily injection under the skin. The purpose of the study is to evaluate how effective and safe metreleptin is for patients with partial lipodystrophy.

Participants in the study will receive metreleptin for a period of 24 months. During this time, researchers will monitor the effects of the treatment on the participants’ health, focusing on changes in blood sugar levels and fat levels in the blood. The study will also look at how the body responds to the treatment over time, including any potential immune reactions. Some participants may receive a placebo, which is a substance with no active medication, to compare the effects of metreleptin.

The study aims to gather information on how metreleptin can help manage symptoms of partial lipodystrophy, such as high blood sugar and high levels of fats in the blood. By the end of the study, researchers hope to better understand the benefits and any risks associated with metreleptin treatment for this condition. Participants will be closely monitored throughout the study to ensure their safety and well-being.

]]>